Which agent is NOT targeted by the DuoDote kit?

Which agent is NOT targeted by the DuoDote kit?

• A. Blister agent
• B. Nerve agent
• C. Pulmonary agent
• D. Blood agent

Answer: (A)

DuoDote is designed for nerve agent exposure, using atropine and pralidoxime to counteract acetylcholinesterase inhibition caused by organophosphate nerve agents. Atropine blocks the muscarinic effects (like excessive secretions and bronchospasm), while pralidoxime helps reactivate acetylcholinesterase if given before aging of the enzyme occurs, reducing both muscarinic and nicotinic symptoms. Blister agents, also known as vesicants (such as sulfur mustard), do not produce a cholinergic crisis and have no specific antidote in the DuoDote kit. Treatment is focused on decontamination and supportive care, not on reversing AChE inhibition. Pulmonary and blood agents require their own management approaches and antidotes. Thus, the agent not targeted by the DuoDote kit is blister agent.

DuoDote is designed for nerve agent exposure, using atropine and pralidoxime to counteract acetylcholinesterase inhibition caused by organophosphate nerve agents. Atropine blocks the muscarinic effects (like excessive secretions and bronchospasm), while pralidoxime helps reactivate acetylcholinesterase if given before aging of the enzyme occurs, reducing both muscarinic and nicotinic symptoms.

Blister agents, also known as vesicants (such as sulfur mustard), do not produce a cholinergic crisis and have no specific antidote in the DuoDote kit. Treatment is focused on decontamination and supportive care, not on reversing AChE inhibition. Pulmonary and blood agents require their own management approaches and antidotes.

Thus, the agent not targeted by the DuoDote kit is blister agent.